CJC-1295 with DAC is a modified analog of growth hormone–releasing hormone (GHRH) engineered with a Drug Affinity Complex (DAC) to extend its duration of activity. It has been studied in research settings for its role in growth hormone signaling pathways and endocrine regulatory mechanisms.